Article
Unpacking bedaquiline heteroresistance: the importance of intermediate profiles for phenotypic drug susceptibility testing.
Antimicrobial agents and chemotherapy - 6 Aug 2025
Ismail Nabila, Sirgel Frik, Omar Shaheed Vally, Omar Shatha, de Kock Marianna, Spies Claudia, Folkerts Megan, Theron Grant, Engelthaler Dave, Metcalfe John, Warren Robin M
Abstract excerpt
Phenotypic drug susceptibility testing (pDST) remains a widely used standard for determination of resistance for several drugs for the Mycobacterium tuberculosis complex. Next-generation sequencing technologies can identify heteroresistant populations at low frequencies, but little is known about the impact of heteroresistance on bedaquiline (BDQ) pDST results. We simulated heteroresistance using in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
